value-based contracting
-
Syntax Health Launches Solution To Streamline Value-based Care Contracts
Syntax Health’s new two-sided software-as-a-service solution allows payers and providers (as well as actuaries, network managers and analysts) to collaborate in creating a value-based contract.
-
MedCity Influencers, BioPharma, Legal
Biden’s New Executive Order Could Usher in an Era of Fair and Equitable Drug Pricing
By leveraging its large membership, Medicare could by embracing value-based contracting significantly influence the pharmaceutical market, pitting competing drugs against each other, or encouraging pharmaceutical makers to figure out ways to deliver drugs more cheaply.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Cell and Gene Therapies Push Payers to New Strategies to Assess Outcomes
Cell and gene therapies are offering patients potentially curative treatments for a growing scope of diseases. Insurance companies are trying to figure out how to pay for them. Industry consultants speaking at the HLTH conference offered some strategies they see payers taking to these new therapies.
-
Health Tech, Pharma, Startups, SYN
Lyfegen raises $8M for its value-based drug contracting platform
Lyfegen, a startup that provides software for value-based drug contracting, recently raised $8 million in an oversubscribed Series A financing round. With the new funds, the company — which is based in Switzerland and New York — plans to expand its presence in the U.S., where drug costs are the highest in the world.
-
Consumer / Employer, Health Tech
TCARE gains $17M in Series A funding for family caregiver support solution
The funding round was led by American Family Ventures and brings the company’s total funds to $20 million. With the money, TCARE will grow its team and work to expand its offerings for its existing clients.
-
Devices & Diagnostics, BioPharma, Payers
Like it or not, value-based contracting is coming for drugs and medical devices
Value-based contracts covering the reimbursement of drugs and medical devices are slowly gaining acceptance. A panel at the MedCity News INVEST conference discussed the challenges and opportunities for these contracts, which aim to improve patient outcomes and control the cost of care.
-
Startups, Health Services, Health Tech
New York telemedicine startup Call9 winding down operations
CEO Tim Peck confirmed the news to CNBC, saying the company ran out of the cash it needed to continue to scale the business and was laying off roughly 100 employees.